Sfoglia per Autore
The mammalian CHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1
2008-01-01 Sbroggiò M; Ferretti R; Percivalle E; Gutkowska M; Zylicz A; Michowski W; Kuznicki J; Accornero F; Pacchioni B; Lanfranchi G; Hamm J; Turco E; Silengo L; Tarone G; Brancaccio M.
Tissue-specific KO of ECM proteins
2009-01-01 Brancaccio M; Turco E; Hirsch E
Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients
2009-01-01 Palumbo V; Segat L; Padovan L; Amoroso A; Trimarco B; Izzo R; Lembo G; Zagrosek VR; Knoll R; Brancaccio M; Tarone G; Crovella S
Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
2010-01-01 ACCORNERO Federica; BRANCACCIO Mara; TARONE Guido; LEMBO Giuseppe; CARNEVALE Daniela
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis
2010-01-01 Ferretti R; Palumbo V; Di Savino A; Velasco S; Sbroggiò M; Sportoletti P; Micale L; Turco E; Silengo L; Palumbo G; Hirsch E; Teruya-Feldstein J; Bonaccorsi S; Pandolfi PP; Gatti M; Tarone G; Brancaccio M
Morgana/CHP-1 is a novel chaperone able to protect cells from stress
2010-01-01 Michowski W; Ferretti R; Wisniewska MB; Ambrozkiewicz M; Beresewicz M; Fusella F; Skibinska-Kijek A; Zablocka B; Brancaccio M; Tarone G; Kuznicki J
Morgana haploinsufficiency induces a myeloproliferative disorder like-chronic myeloid leukemia in mice.
2011-01-01 Di Savino A; Morotti A; Ferretti R; Panuzzo C; Familiari U; Camporeale A; Miniscalco B; Fusella F; Papotti M; Saglio G; Tarone G; Brancaccio M
IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
2011-01-01 Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
Morgana and Melusin: Two fairies chaperoning signal transduction.
2011-01-01 Ferretti R; Sbroggiò M; Di Savino A; Fusella F; Bertero A; Michowski W; Tarone G; Brancaccio M.
Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.
2011-01-01 Kazuhiko Hanashiro; Mara Brancaccio; Kenji Fukasawa
ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1.
2011-01-01 Sbroggiò M; Bertero A; Velasco S; Fusella F; De Blasio E; Bahou WF; Silengo L; Turco E; Brancaccio M; Tarone G.
Phosphoinositide 3-kinase (P110alpha) directly regulates key components of the Z-disc and cardiac structure.
2011-01-01 Waardenberg AJ; Bernardo BC; Ng DC; Shepherd PR; Cemerlang N; Sbroggio M; Wells CA; Dalrymple BP; Brancaccio M; Lin RC; McMullen JR
Key role of ERK1/2 molecular scaffolds in heart pathology.
2013-01-01 Tarone G;Sbroggiò M;Brancaccio M
MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA
2014-01-01 Di Savino A; Panuzzo C; Rocca S; Familiari U; Piazza R; Crivellaro S; Carrà G; Ferretti R; Fusella F; Giugliano E; Camporeale A; Franco I; Miniscalco B; Cutrin JC; Turco E; Silengo L; Hirsch E; Gambacorti-Passerini C; Pandolfi PP; Papotti M; Saglio G; Tarone G; Morotti A; Brancaccio M
Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction.
2014-01-01 Unsöld B; Kaul A; Sbroggiò M; Schubert C; Regitz-Zagrosek V; Brancaccio M; Damilano F; Hirsch E; Van Bilsen M; Munts C; Sipido K; Bito V; Detre E; Wagner NM; Schäfer K; Seidler T; Vogt J; Neef S; Bleckmann A; Maier LS; Balligand JL; Bouzin C; Ventura-Clapier R; Garnier A; Eschenhagen T; El-Armouche A; Knöll R; Tarone G; Hasenfuß G
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway.
2014-01-01 Fusella F; Ferretti R; Recupero D; Rocca S; Di Savino A; Tornillo G; Silengo L; Turco E; Cabodi S; Provero P; Pandolfi PP; Sapino A; Tarone G; Brancaccio M.
Morgana is a new oncosuppressor in CML
2014-01-01 Augusta Di Savino; Cristina Panuzzo; Stefania Rocca; Ubaldo Familiari; Roberta Ferretti; Federica Fusella; Rocco Piazza; Carlo Gambacorti Passerini; Emilia Giuliano; Sabrina Crivellaro; Giovanna Carrà; Annalisa Camporeale; Barbara Miniscalco; Juan Carlos Cutrin; Emilia Turco; Lorenzo Silengo; Emilio Hirsch; Mauro Papotti; Pier Paolo Pandolfi; Giuseppe Saglio; Guido Tarone; Alessandro Morotti; Mara Brancaccio
Keep your heart in shape: molecular chaperone networks for treating heart disease.
2014-01-01 Tarone G;Brancaccio M
Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
2014-01-01 Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G.
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML
2015-01-01 C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The mammalian CHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1 | 2008 | Sbroggiò M; Ferretti R; Percivalle E; Gutkowska M; Zylicz A; Michowski W; Kuznicki J; Accornero F; Pacchioni B; Lanfranchi G; Hamm J; Turco E; Silengo L; Tarone G; Brancaccio M. | |
| Tissue-specific KO of ECM proteins | 2009 | Brancaccio M; Turco E; Hirsch E | |
| Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients | 2009 | Palumbo V; Segat L; Padovan L; Amoroso A; Trimarco B; Izzo R; Lembo G; Zagrosek VR; Knoll R; Brancaccio M; Tarone G; Crovella S | |
| Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof | 2010 | ACCORNERO Federica; BRANCACCIO Mara; TARONE Guido; LEMBO Giuseppe; CARNEVALE Daniela | |
| Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis | 2010 | Ferretti R; Palumbo V; Di Savino A; Velasco S; Sbroggiò M; Sportoletti P; Micale L; Turco E; Silengo L; Palumbo G; Hirsch E; Teruya-Feldstein J; Bonaccorsi S; Pandolfi PP; Gatti M; Tarone G; Brancaccio M | |
| Morgana/CHP-1 is a novel chaperone able to protect cells from stress | 2010 | Michowski W; Ferretti R; Wisniewska MB; Ambrozkiewicz M; Beresewicz M; Fusella F; Skibinska-Kijek A; Zablocka B; Brancaccio M; Tarone G; Kuznicki J | |
| Morgana haploinsufficiency induces a myeloproliferative disorder like-chronic myeloid leukemia in mice. | 2011 | Di Savino A; Morotti A; Ferretti R; Panuzzo C; Familiari U; Camporeale A; Miniscalco B; Fusella F; Papotti M; Saglio G; Tarone G; Brancaccio M | |
| IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. | 2011 | Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G | |
| Morgana and Melusin: Two fairies chaperoning signal transduction. | 2011 | Ferretti R; Sbroggiò M; Di Savino A; Fusella F; Bertero A; Michowski W; Tarone G; Brancaccio M. | |
| Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification. | 2011 | Kazuhiko Hanashiro; Mara Brancaccio; Kenji Fukasawa | |
| ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1. | 2011 | Sbroggiò M; Bertero A; Velasco S; Fusella F; De Blasio E; Bahou WF; Silengo L; Turco E; Brancaccio M; Tarone G. | |
| Phosphoinositide 3-kinase (P110alpha) directly regulates key components of the Z-disc and cardiac structure. | 2011 | Waardenberg AJ; Bernardo BC; Ng DC; Shepherd PR; Cemerlang N; Sbroggio M; Wells CA; Dalrymple BP; Brancaccio M; Lin RC; McMullen JR | |
| Key role of ERK1/2 molecular scaffolds in heart pathology. | 2013 | Tarone G;Sbroggiò M;Brancaccio M | |
| MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA | 2014 | Di Savino A; Panuzzo C; Rocca S; Familiari U; Piazza R; Crivellaro S; Carrà G; Ferretti R; Fusella F; Giugliano E; Camporeale A; Franco I; Miniscalco B; Cutrin JC; Turco E; Silengo L; Hirsch E; Gambacorti-Passerini C; Pandolfi PP; Papotti M; Saglio G; Tarone G; Morotti A; Brancaccio M | |
| Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction. | 2014 | Unsöld B; Kaul A; Sbroggiò M; Schubert C; Regitz-Zagrosek V; Brancaccio M; Damilano F; Hirsch E; Van Bilsen M; Munts C; Sipido K; Bito V; Detre E; Wagner NM; Schäfer K; Seidler T; Vogt J; Neef S; Bleckmann A; Maier LS; Balligand JL; Bouzin C; Ventura-Clapier R; Garnier A; Eschenhagen T; El-Armouche A; Knöll R; Tarone G; Hasenfuß G | |
| Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. | 2014 | Fusella F; Ferretti R; Recupero D; Rocca S; Di Savino A; Tornillo G; Silengo L; Turco E; Cabodi S; Provero P; Pandolfi PP; Sapino A; Tarone G; Brancaccio M. | |
| Morgana is a new oncosuppressor in CML | 2014 | Augusta Di Savino; Cristina Panuzzo; Stefania Rocca; Ubaldo Familiari; Roberta Ferretti; Federica Fusella; Rocco Piazza; Carlo Gambacorti Passerini; Emilia Giuliano; Sabrina Crivellaro; Giovanna Carrà; Annalisa Camporeale; Barbara Miniscalco; Juan Carlos Cutrin; Emilia Turco; Lorenzo Silengo; Emilio Hirsch; Mauro Papotti; Pier Paolo Pandolfi; Giuseppe Saglio; Guido Tarone; Alessandro Morotti; Mara Brancaccio | |
| Keep your heart in shape: molecular chaperone networks for treating heart disease. | 2014 | Tarone G;Brancaccio M | |
| Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury. | 2014 | Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G. | |
| ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML | 2015 | C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile